Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  ACTIVE SITE THROMBIN INHIBITORS
 
Authors :  M. J. Hartshorn, C. W. Murray, A. Cleasby, M. Frederickson, I. J. Tickle
Date :  28 Oct 04  (Deposition) - 27 Jan 05  (Release) - 28 Jun 17  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.02
Chains :  Asym./Biol. Unit :  A,B,I
Keywords :  Protease, Blood Coagulation, Acute Phase, Calcium-Binding, Disease Mutation, Gamma-Carboxyglutamic Acid, Glycoprotein, Kringle, Plasma, Serine Protease, Vitamin K, Hydrolase-Hydrolase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  M. J. Hartshorn, C. W. Murray, A. Cleasby, M. Frederickson, I. J. Tickle, H. Jhoti
Fragment-Based Lead Discovery Using X-Ray Crystallography
J. Med. Chem. V. 48 403 2005
PubMed-ID: 15658854  |  Reference-DOI: 10.1021/JM0495778

(-) Compounds

Molecule 1 - THROMBIN LIGHT CHAIN
    ChainsA
    EC Number3.4.21.5
    FragmentFRAGMENT ALPHA THROMBIN, RESIDUES 328-363
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymCOAGULATION FACTOR II
    TissueBLOOD PLASMA
 
Molecule 2 - THROMBIN HEAVY CHAIN
    ChainsB
    EC Number3.4.21.5
    FragmentFRAGMENT ALPHA THROMBIN, RESIDUES 364-622
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymCOAGULATION FACTOR II
    TissueBLOOD PLASMA
 
Molecule 3 - HIRUGEN
    ChainsI
    EngineeredYES
    FragmentPEPTIDE FRAGMENT OF HIRUGEN, RESIDUES 62-71
    Organism CommonMEDICINAL LEECH
    Organism ScientificHIRUDO MEDICINALIS
    Organism Taxid6421
    SyntheticYES

 Structural Features

(-) Chains, Units

  123
Asymmetric/Biological Unit ABI

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 5)

Asymmetric/Biological Unit (3, 5)
No.NameCountTypeFull Name
1DMS3Ligand/IonDIMETHYL SULFOXIDE
2L021Ligand/Ion4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE
3TYS1Mod. Amino AcidO-SULFO-L-TYROSINE

(-) Sites  (5, 5)

Asymmetric Unit (5, 5)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREASP B:189 , ALA B:190 , CYS B:191 , GLU B:192 , VAL B:213 , TRP B:215 , GLY B:219 , CYS B:220 , GLY B:226 , PHE B:227 , HOH B:2286BINDING SITE FOR RESIDUE L02 B 1248
2AC2SOFTWARELEU B:130 , ARG B:165 , PHE B:181 , HOH B:2230BINDING SITE FOR RESIDUE DMS B 1249
3AC3SOFTWAREASN B:98 , TRP B:215BINDING SITE FOR RESIDUE DMS B 1250
4AC4SOFTWAREGLY B:223 , LYS B:224BINDING SITE FOR RESIDUE DMS B 1251
5AC5SOFTWAREPHE B:34 , GLN B:38 , LEU B:65 , ARG B:73 , THR B:74 , ARG B:75 , TYR B:76 , GLU B:80 , LYS B:81 , ILE B:82 , SER B:153 , HOH B:2069 , HOH B:2129 , HOH B:2134 , HOH I:2003 , HOH I:2004 , HOH I:2005 , HOH I:2008BINDING SITE FOR CHAIN I OF HIRUGEN

(-) SS Bonds  (4, 4)

Asymmetric/Biological Unit
No.Residues
1A:1 -B:122
2B:42 -B:58
3B:168 -B:182
4B:191 -B:220

(-) Cis Peptide Bonds  (1, 1)

Asymmetric/Biological Unit
No.Residues
1Ser B:37 -Pro B:37A

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (8, 8)

Asymmetric/Biological Unit (8, 8)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_006714M380TTHRB_HUMANDisease (FA2D)121918481BM32T
2UniProtVAR_006715R425CTHRB_HUMANDisease (FA2D)121918479BR67C
3UniProtVAR_006716R431HTHRB_HUMANDisease (FA2D)121918482BR73H
4UniProtVAR_006717R461WTHRB_HUMANDisease (FA2D)121918478BR101W
5UniProtVAR_006718E509ATHRB_HUMANDisease (FA2D)  ---BE146A
6UniProtVAR_068913E532QTHRB_HUMANPolymorphism  ---BE164Q
7UniProtVAR_006719G601VTHRB_HUMANDisease (FA2D)121918480BG226V
8UniProtVAR_011782P386TTHRB_HUMANPolymorphism5897BP37AT

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 3)

Asymmetric/Biological Unit (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TRYPSIN_DOMPS50240 Serine proteases, trypsin domain profile.THRB_HUMAN364-618  1B:16-243
2TRYPSIN_HISPS00134 Serine proteases, trypsin family, histidine active site.THRB_HUMAN402-407  1B:53-58
3TRYPSIN_SERPS00135 Serine proteases, trypsin family, serine active site.THRB_HUMAN562-573  1B:189-200

(-) Exons   (7, 8)

Asymmetric/Biological Unit (7, 8)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003119071aENSE00001931088chr11:46740730-46740864135THRB_HUMAN1-27270--
1.2aENST000003119072aENSE00001181543chr11:46741252-46741412161THRB_HUMAN27-80540--
1.3ENST000003119073ENSE00001181538chr11:46742073-4674209725THRB_HUMAN81-8990--
1.4ENST000003119074ENSE00001181532chr11:46742340-4674239051THRB_HUMAN89-106180--
1.6aENST000003119076aENSE00001181527chr11:46744730-46744835106THRB_HUMAN106-141360--
1.6cENST000003119076cENSE00001181524chr11:46744932-46745068137THRB_HUMAN141-187470--
1.7bENST000003119077bENSE00001688723chr11:46747409-46747723315THRB_HUMAN187-2921060--
1.8ENST000003119078ENSE00002179953chr11:46748048-46748176129THRB_HUMAN292-335441A:1D-1A
-
4
-
1.9ENST000003119079ENSE00001770269chr11:46748261-46748387127THRB_HUMAN335-377432A:1A-14K
B:16-29
26
14
1.10ENST0000031190710ENSE00001650441chr11:46749546-46749713168THRB_HUMAN377-433571-
B:29-75
-
57
1.11bENST0000031190711bENSE00001657931chr11:46750214-46750387174THRB_HUMAN433-491591-
B:75-129B
-
59
1.12ENST0000031190712ENSE00001646362chr11:46750930-46751111182THRB_HUMAN491-552621-
B:129B-184A (gaps)
-
62
1.13ENST0000031190713ENSE00001680217chr11:46760598-4676066871THRB_HUMAN552-575241-
B:184A-202
-
24
1.14cENST0000031190714cENSE00001227030chr11:46760815-46761056242THRB_HUMAN576-622471-
B:203-247 (gaps)
-
48

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:29
 aligned with THRB_HUMAN | P00734 from UniProtKB/Swiss-Prot  Length:622

    Alignment length:29
                                   341       351         
          THRB_HUMAN    332 GEADCGLRPLFEKKSLEDKTERELLESYI  360
               SCOP domains ----------------------------- SCOP domains
               CATH domains ----------------------------- CATH domains
               Pfam domains Thrombin_light-1wayA01        Pfam domains
         Sec.struct. author ..........hhhhh....hhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ----------------------------- SAPs(SNPs)
                PROSITE (1) ----------------------------- PROSITE (1)
                PROSITE (2) ----------------------------- PROSITE (2)
           Transcript 1 (1) 1.8 ------------------------- Transcript 1 (1)
           Transcript 1 (2) ---Exon 1.9  PDB: A:1A-14K    Transcript 1 (2)
                1way A   1D GEADCGLRPLFEKKSLEDKTERELLESYI  14K
                            ||||     6       14B|||||||||
                            ||||            14A||||||14J|
                           1D|||             14B||||||14K
                            1C||              14C||||||  
                             1B|               14D|||||  
                              1A                14E||||  
                                                 14F|||  
                                                  14G||  
                                                   14H|  
                                                    14I  

Chain B from PDB  Type:PROTEIN  Length:251
 aligned with THRB_HUMAN | P00734 from UniProtKB/Swiss-Prot  Length:622

    Alignment length:259
                                   373       383       393       403       413       423       433       443       453       463       473       483       493       503       513       523       533       543       553       563       573       583       593       603       613         
          THRB_HUMAN    364 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE  622
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 1wayB01     1wayB02 B:28-120,B:233-246 Trypsin-like serine proteases                                                 1wayB01 B:16-27,B:121-232 Try        psin-like serine proteases                                                                1wayB02       - CATH domains
               Pfam domains Trypsin-1wayB01 B:16-238                                                                                                                                                                                                                                  --------- Pfam domains
         Sec.struct. author ....ee........eeeeee....eeeeeeee....eeeehhhh.eehhhhee.hhh.eeeee.............eeeeeeeeee..............eeeee................hhhhhhhhh....eeeeee......--------......eeeeee..hhhhhhhh........eeee..hhhhh............eeeee......eeeeeeeee..........eeeee...hhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ----------------T-----T--------------------------------------C-----H-----------------------------W-----------------------------------------------A----------------------Q--------------------------------------------------------------------V--------------------- SAPs(SNPs)
                PROSITE (1) TRYPSIN_DOM  PDB: B:16-243 UniProt: 364-618                                                                                                                                                                                                                    ---- PROSITE (1)
                PROSITE (2) --------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER ------------------------------------------------- PROSITE (2)
           Transcript 1 (1) -------------Exon 1.10  PDB: B:29-75 UniProt: 377-433                 ---------------------------------------------------------Exon 1.12  PDB: B:129B-184A (gaps) UniProt: 491-552           -----------------------Exon 1.14c  PDB: B:203-247 (gaps)               Transcript 1 (1)
           Transcript 1 (2) Exon 1.9      -------------------------------------------------------Exon 1.11b  PDB: B:75-129B UniProt: 433-491                ------------------------------------------------------------Exon 1.13               ----------------------------------------------- Transcript 1 (2)
                1way B   16 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKE--------GQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE  247
                                    25        35  |     44        54      |60D|||||   65        75  |     84        94   |   103       113       123      |130       140     |   -    |  155       165       175       184  |||| 190       200    || 208       219  |    228       238         
                                                37A                     60A||||||||               77A                  97A                             129A||              146      150                              184A   ||||               204A|          217|  |                          
                                                                         60B|||||||                                                                     129B|                                                            186A|||                204B           219  |                          
                                                                          60C||||||                                                                      129C                                                             186B||                                 221A                          
                                                                           60D|||||                                                                                                                                        186C|                                                               
                                                                            60E||||                                                                                                                                         186D                                                               
                                                                             60F|||                                                                                                                                                                                                            
                                                                              60G||                                                                                                                                                                                                            
                                                                               60H|                                                                                                                                                                                                            
                                                                                60I                                                                                                                                                                                                            

Chain I from PDB  Type:PROTEIN  Length:10
 aligned with HIRV2_HIRME | P09945 from UniProtKB/Swiss-Prot  Length:72

    Alignment length:10
                                    71
         HIRV2_HIRME     62 DFEEIPEEYL   71
               SCOP domains ---------- SCOP domains
               CATH domains ---------- CATH domains
               Pfam domains Hirudin-1w Pfam domains
         Sec.struct. author .....hhhhh Sec.struct. author
                 SAPs(SNPs) ---------- SAPs(SNPs)
                    PROSITE ---------- PROSITE
                 Transcript ---------- Transcript
                1way I   55 DFEEIPEEyL   64
                                    64
                                   63-TYS

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 1WAY)

(-) CATH Domains  (1, 2)

Asymmetric/Biological Unit
(-)
Class: Mainly Beta (13760)

(-) Pfam Domains  (3, 3)

Asymmetric/Biological Unit

(-) Gene Ontology  (56, 57)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A,B   (THRB_HUMAN | P00734)
molecular function
    GO:0005509    calcium ion binding    Interacting selectively and non-covalently with calcium ions (Ca2+).
    GO:0008083    growth factor activity    The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0005102    receptor binding    Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
    GO:0004252    serine-type endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0008236    serine-type peptidase activity    Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
    GO:0070053    thrombospondin receptor activity    Combining with thrombospondin and transmitting the signal to initiate a change in cell activity.
biological process
    GO:0006888    ER to Golgi vesicle-mediated transport    The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
    GO:0006953    acute-phase response    An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
    GO:0007596    blood coagulation    The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
    GO:0007597    blood coagulation, intrinsic pathway    A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
    GO:0007166    cell surface receptor signaling pathway    A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0044267    cellular protein metabolic process    The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
    GO:0071260    cellular response to mechanical stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
    GO:0042730    fibrinolysis    A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin.
    GO:0007599    hemostasis    The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
    GO:0050900    leukocyte migration    The movement of a leukocyte within or between different tissues and organs of the body.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0048712    negative regulation of astrocyte differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of astrocyte differentiation.
    GO:0051918    negative regulation of fibrinolysis    Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots.
    GO:0010544    negative regulation of platelet activation    Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue.
    GO:0045861    negative regulation of proteolysis    Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.
    GO:0017187    peptidyl-glutamic acid carboxylation    The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
    GO:0030168    platelet activation    A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
    GO:0030194    positive regulation of blood coagulation    Any process that activates or increases the frequency, rate or extent of blood coagulation.
    GO:0030307    positive regulation of cell growth    Any process that activates or increases the frequency, rate, extent or direction of cell growth.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0032967    positive regulation of collagen biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
    GO:0014068    positive regulation of phosphatidylinositol 3-kinase signaling    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:1900738    positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway    Any process that activates or increases the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:2000379    positive regulation of reactive oxygen species metabolic process    Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
    GO:0051281    positive regulation of release of sequestered calcium ion into cytosol    Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0030193    regulation of blood coagulation    Any process that modulates the frequency, rate or extent of blood coagulation.
    GO:0008360    regulation of cell shape    Any process that modulates the surface configuration of a cell.
    GO:0051480    regulation of cytosolic calcium ion concentration    Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings.
    GO:0010468    regulation of gene expression    Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
    GO:0014854    response to inactivity    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inactivity stimulus.
    GO:0009611    response to wounding    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
    GO:0006465    signal peptide processing    The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
cellular component
    GO:0005796    Golgi lumen    The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
    GO:0072562    blood microparticle    A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
    GO:0005788    endoplasmic reticulum lumen    The volume enclosed by the membranes of the endoplasmic reticulum.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0031012    extracellular matrix    A structure lying external to one or more cells, which provides structural support for cells or tissues.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain I   (HIRV2_HIRME | P09945)
molecular function
    GO:0004857    enzyme inhibitor activity    Binds to and stops, prevents or reduces the activity of an enzyme.
    GO:0030414    peptidase inhibitor activity    Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
    GO:0004867    serine-type endopeptidase inhibitor activity    Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
    GO:0010951    negative regulation of endopeptidase activity    Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
    GO:0010466    negative regulation of peptidase activity    Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
cellular component
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    DMS  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    L02  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    TYS  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ser B:37 - Pro B:37A  [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  1way
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  HIRV2_HIRME | P09945
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  THRB_HUMAN | P00734
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.21.5
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  613679
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  HIRV2_HIRME | P09945
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  THRB_HUMAN | P00734
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        HIRV2_HIRME | P099451a2c 1a46 1a4w 1a5g 1a61 1b5g 1doj 1hgt 1k21 1k22 1nrs 1tbz 1tmb 1tmu 1vzq 1w7g 1wbg 2bvr 2bvs 2bvx 2bxt 2bxu 2c8w 2c8x 2c8y 2c8z 2c90 2c93 2r2m 2zfq 2zfr 2zg0 2zhe 2zhf 2zhw 3biu 3biv 3f68 3hat 3htc 3p17 3qto 3qtv 3qwc 3qx5 3rlw 3rly 3rm0 3rm2 3rml 3rmm 3rmn 3rmo 3sha 3shc 3si3 3si4 3sv2 3t5f 3tu7 3u98 3u9a 3uwj 4bao 4e7r 4htc 4loy 4n3l 4nze 4ud9 4udw 4ue7 4ueh 4ufd 4ufe 4uff 4ufg 5a2m 5af9 5jfd 5jzy
        THRB_HUMAN | P007341a2c 1a3b 1a3e 1a46 1a4w 1a5g 1a61 1abi 1abj 1ad8 1ae8 1afe 1aht 1ai8 1aix 1awf 1awh 1ay6 1b5g 1b7x 1ba8 1bb0 1bcu 1bhx 1bmm 1bmn 1bth 1c1u 1c1v 1c1w 1c4u 1c4v 1c4y 1c5l 1c5n 1c5o 1ca8 1d3d 1d3p 1d3q 1d3t 1d4p 1d6w 1d9i 1de7 1dit 1dm4 1doj 1dwb 1dwc 1dwd 1dwe 1dx5 1e0f 1eb1 1eoj 1eol 1fpc 1fph 1g30 1g32 1g37 1ghv 1ghw 1ghx 1ghy 1gj4 1gj5 1h8d 1h8i 1hag 1hah 1hai 1hao 1hap 1hbt 1hdt 1hgt 1hlt 1hut 1hxe 1hxf 1ihs 1iht 1jmo 1jou 1jwt 1k21 1k22 1kts 1ktt 1lhc 1lhd 1lhe 1lhf 1lhg 1mh0 1mu6 1mu8 1mue 1nm6 1no9 1nrn 1nro 1nrp 1nrq 1nrr 1nrs 1nt1 1nu7 1nu9 1ny2 1nzq 1o0d 1o2g 1o5g 1ook 1oyt 1p8v 1ppb 1qbv 1qhr 1qj1 1qj6 1qj7 1qur 1rd3 1riw 1sb1 1sfq 1sg8 1sgi 1shh 1sl3 1sr5 1t4u 1t4v 1ta2 1ta6 1tb6 1tbz 1thp 1thr 1ths 1tmb 1tmt 1tmu 1tom 1tq0 1tq7 1twx 1uma 1uvs 1vr1 1vzq 1w7g 1wbg 1xm1 1xmn 1ype 1ypg 1ypj 1ypk 1ypl 1ypm 1z71 1z8i 1z8j 1zgi 1zgv 1zrb 2a0q 2a2x 2a45 2afq 2ank 2anm 2b5t 2bdy 2bvr 2bvs 2bvx 2bxt 2bxu 2c8w 2c8x 2c8y 2c8z 2c90 2c93 2cf8 2cf9 2cn0 2feq 2fes 2gde 2gp9 2h9t 2hgt 2hnt 2hpp 2hpq 2hwl 2jh0 2jh5 2jh6 2od3 2pgb 2pgq 2pks 2pw8 2r2m 2thf 2uuf 2uuj 2uuk 2v3h 2v3o 2zc9 2zda 2zdv 2zf0 2zff 2zfp 2zfq 2zfr 2zg0 2zgb 2zgx 2zhe 2zhf 2zhq 2zhw 2zi2 2ziq 2znk 2zo3 3b23 3b9f 3bef 3bei 3bf6 3biu 3biv 3bv9 3c1k 3c27 3d49 3da9 3dd2 3dhk 3dt0 3dux 3e6p 3ee0 3egk 3eq0 3f68 3gic 3gis 3hat 3hkj 3htc 3jz1 3jz2 3k65 3ldx 3lu9 3nxp 3p17 3p6z 3p70 3pmh 3po1 3qdz 3qgn 3qlp 3qto 3qtv 3qwc 3qx5 3r3g 3rlw 3rly 3rm0 3rm2 3rml 3rmm 3rmn 3rmo 3s7h 3s7k 3sha 3shc 3si3 3si4 3sqe 3sqh 3sv2 3t5f 3tu7 3u69 3u8o 3u8r 3u8t 3u98 3u9a 3utu 3uwj 3vxe 3vxf 4ax9 4ayv 4ayy 4az2 4bah 4bak 4bam 4ban 4bao 4baq 4boh 4ch2 4ch8 4dih 4dii 4dt7 4dy7 4e05 4e06 4e7r 4h6s 4h6t 4hfp 4htc 4hzh 4i7y 4loy 4lxb 4lz1 4lz4 4mlf 4n3l 4nze 4nzq 4o03 4rkj 4rko 4rn6 4thn 4ud9 4udw 4ue7 4ueh 4ufd 4ufe 4uff 4ufg 4yes 5a2m 5af9 5afy 5afz 5ahg 5cmx 5do4 5e8e 5edk 5edm 5ew1 5ew2 5gds 5gim 5jdu 5jfd 5jzy 5l6n 5luw 5luy 5nhu 5to3 7kme 8kme

(-) Related Entries Specified in the PDB File

1a2c STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE- GREEN ALGA
1a3b COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1
1a3e COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2
1a46 THROMBIN COMPLEXED WITH HIRUGEN AND A BETA- STRAND MIMETIC INHIBITOR
1a4w CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE- CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE
1a5g HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1a61 THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR
1abi ALPHA-THROMBIN COMPLEX WITH HIRULOG 3
1abj ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1ad8 COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY
1ae8 HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D- PHE-PRO-AZALYS-ONP
1afe HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO- AZALYS-ONP
1aht MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ ID: 2; MOLECULE: HIRUGEN; CHAIN: I; HETEROGEN: P- AMIDINO-PHENYL- PYRUVATE
1ai8 HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA- PRO-BOROMPG
1aix HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL
1awf NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1awh NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1ay6 THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF
1b5g HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1b7x STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D- PHE-PRO- ARG- CHLOROMETHYLKETONE
1ba8 THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES
1bb0 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1bcu ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN
1bhx X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229- 357
1bmm HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-4- [(AMINOIMINOMETHYL)AMINO]-N-[[1-[3- HYDROXY-2-[(2- NAPHTHALENYLSULFONYL)AMINO]-1- OXOPROPYL]-2-PYRROLIDINYL] METHYL] BUTANAMIDE (BMS-186282)
1bmn HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R, R)]-1- (AMINOIMINOMETHYL) -N-[[1-[N-[(2- NAPHTHALENYLSULFONYL)-L- SERYL]-PYRROLIDINYL] METHYL] -3-PIPERIDENECARBOXAMIDE (BMS- 189090)
1bth STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1c1u RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1c1v RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1c1w RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1c4u SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1c4v SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1c4y SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS
1c5l STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1c5n STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1c5o STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1- BINDING, SUB- MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1ca8 THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1d3d CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4
1d3p CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B] THIOPHENE INHIBITOR 3
1d3q CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] THIOPHENE INHIBITOR 2
1d3t CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B] THIOPHENE INHIBITOR 1
1d4p CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5- AMIDINOINDOLE-4- BENZYLPIPERIDINE INHIBITOR
1d6w STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1
1d9i STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON- ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1
1de7 INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA- THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX
1dit COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN
1dm4 SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16)
1doj CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN* RWJ-51438 COMPLEXAT 1.7 A
1dwb ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 - 65) AND BENZAMIDINE
1dwc ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 - 65) AND MD-805 (ARGATROBAN)
1dwd ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 - 65) AND NAPAP
1dwe ALPHA-THROMBIN COMPLEX WITH (DES-AMINO ASP 55) HIRUDIN (RESIDUES 55 - 65) AND D-PHE- PRO-ARG-CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1dx5 CRYSTAL STRUCTURE OF THE THROMBIN- THROMBOMODULIN COMPLEX
1e0f CRYSTAL STRUCTURE OF THE HUMAN ALPHA- THROMBIN-HAEMADIN COMPLEX: AN EXOSITE II- BINDING INHIBITOR
1eb1 COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N- METHYL-ARGININE INHIBITOR
1eoj DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES
1eol DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES
1fpc ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR DANSYLARGININE N-(3-ETHYL -1,5-PENTANEDIYL) AMIDE (DAPA)
1fph ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN AND FIBRINOPEPTIDE A
1g30 THROMBIN INHIBITOR COMPLEX
1g32 THROMBIN INHIBITOR COMPLEX
1g37 CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITHBCH -10556 AND EXOSITE-DIRECTED PEPTIDE
1ghv A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1ghw A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1ghx A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1ghy A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI- CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1gj4 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN
1gj5 SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA,SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN
1h8d X-RAY STRUCTURE OF THE HUMAN ALPHA- THROMBIN COMPLEX WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.
1h8i X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA- THROMBIN WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.
1hag PRETHROMBIN2 COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 WITH SULFATO-TYR 63)
1hah ALPHA THROMBIN COMPLEXED WITH HIRUGEN (N- ACETYLHIRUDIN 53 - 64 WITH SULFATO-TYR 63)
1hai ALPHA THROMBIN COMPLEXED WITH D-PHE-PRO- ARG- CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1hao COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF DEOXYRIBONUCLEIC ACID)
1hap COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF DEOXYRIBONUCLEIC ACID)
1hbt HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR
1hdt MOL_ID: 1; MOLECULE: ALPHA-THROMBIN; CHAIN: L, H; EC: 3.4.21.5; MOL_ ID: 2; MOLECULE: HIRUGEN PEPTIDE; CHAIN: P; ENGINEERED: YES; MOL_ID: 3; MOLECULE: N-[N -[N-[4- (AMINOIMINOMETHYL)AMINO]-1-OXOBUTYL]- L - PHENYLALANYL]-L- ALLO-THREONYL-L- PHENYLALANINE, METHYL ESTER (BMS- 183507); CHAIN: I; ENGINEERED: YES
1hgt ALPHA-THROMBIN COMPLEX WITH HIRUGEN
1hlt ALPHA THROMBIN COMPLEXED WITH THROMBOMODULIN (NONDECAPEPTIDE) AND D- PHE-PRO-ARG- CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1hut ALPHA-THROMBIN COMPLEXED WITH DEOXYRIBONUCLEIC ACID (5'- D(GPGPTPTPGPGPTPGPTPGPGPTPTPGPG)-3') AND D-PHE-PRO-ARG- CHLOROMETHYLKETONE (PPACK ) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1hxe SERINE PROTEASE
1hxf HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT
1ihs ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-2
1iht ALPHA-THROMBIN COMPLEX WITH HIRUTONIN-6
1jmo CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II -S195A THROMBINCOMPLEX
1jou CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH ANUNOCCUPIED ACTIVE SITE
1jwt CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVELBICYCLIC LACTAM INHIBITOR
1k21 HUMAN THROMBIN-INHIBITOR COMPLEX
1k22 HUMAN THROMBIN-INHIBITOR COMPLEX
1kts THROMBIN INHIBITOR COMPLEX
1ktt THROMBIN INHIBITOR COMPLEX
1lhc HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROARG- OH
1lhd HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BOROLYS- OH
1lhe HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO-N- BUTYL- AMIDINO-GLYCINE-OH
1lhf HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO-BORO- HOMOLYS-OH
1lhg HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D) PHE-PRO- BOROORNITHINE-OH
1mh0 CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN
1mu6 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622
1mu8 THROMBIN-HIRUGEN_L-378,650
1mue THROMBIN-HIRUGEN-L405,426
1nm6 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT1.8A
1no9 DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATINGNOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X- RAYCRYSTALLOGRAPHIC STUDIES.
1nrn ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE NRS
1nro ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE NRP
1nrp ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE NR'S
1nrq ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE D-FPR'S
1nrr ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE XA AND D-PHE-PRO- ARG CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1nrs ALPHA-THROMBIN NON-COVALENTLY COMPLEXED WITH RECEPTOR BASED PEPTIDE NRP (CLEAVED, FIRST FOUR RESIDUES ONLY) AND HIRUGEN
1nt1 THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR
1nu7 STAPHYLOCOAGULASE-THROMBIN COMPLEX
1nu9 STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX
1ny2 HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN
1nzq D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR
1o0d HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO -ARG- TYPEINHIBITOR AND A C-TERMINAL HIRUDIN DERIVED EXO- SITEINHIBITOR
1o2g ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATINGBINDING OF ACTIVE SITE- DIRECTED SERINE PROTEASE INHIBITORS
1o5g DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA)
1ook CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA AND HUMAN ALPHA- THROMBIN
1oyt COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNEDFLUORINATED INHIBITOR
1p8v CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB- ALPHA AND ALPHA-THROMBIN AT 2.6A
1ppb ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) WITH CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP
1qbv CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE- MIMETIC INHIBITOR
1qhr NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1qj1 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1qj6 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1qj7 NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1qur HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE- BASED SYNTHETIC INHIBITOR
1qvh CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THECENTRAL "E" REGION OF FIBRIN
1rd3 2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K
1riw THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOROSCILLARIN
1sb1 NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4, 5,6,7- TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS
1sfq FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK
1sg8 CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN
1sgi CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN
1shh SLOW FORM OF THROMBIN BOUND WITH PPACK
1sl3 CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1HETEROCYCLE- ARYL BASED INHIBITOR
1sr5 ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEXSTRUCTURE
1ta2 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1
1ta6 CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B
1tb6 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN- THROMBIN- HEPARINTERNARY COMPLEX
1tbz HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N- [5- (AMINOIMINOMETHYL)AMINO]- 1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L- PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN
1thp STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D- PHE-PRO- ARG- CHLOROMETHYLKETONE
1thr ALPHA-THROMBIN COMPLEX WITH HIRULLIN
1ths ALPHA-THROMBIN COMPLEX WITH MDL-28050
1tmb ALPHA-THROMBIN COMPLEX WITH HIRUGEN AND CYCLOTHEONAMIDE A
1tmt ALPHA-THROMBIN COMPLEXED WITH CGP 50,856 (D-PHE-PRO-ARG-PRO -GLY- GLY-GLY-GLY FOLLOWED BY RESIDUES 53 - 65 OF HIRUDIN, CLEAVED AFTER ARG I 3)
1tmu ALPHA-THROMBIN TERNARY COMPLEX WITH HIRUDIN (C-TERMINAL FRAGMENT, RESIDUES 55 - 65) AND PPACK (D-PHE-PRO-ARG- CHLOROMETHYLKETONE)
1tom ALPHA-THROMBIN COMPLEXED WITH HIRUGEN
1tq0 CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT THROMBINMUTANT W215A/ E217A IN FREE FORM
1tq7 CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANTW215A/E217A BOUND TO PPACK
1uma ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N- DIMETHYLCARBAMOYL)- ALPHA-AZALYSINE
1uvs BOVINE THROMBIN--BM51.1011 COMPLEX
1vr1 SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR- 1
1vzq COMPLEX OF THROMBIN WITH DESIGNED INHIBITOR 7165
1w7g ALPHA-THROMBIN COMPLEX WITH SULFATED HIRUDIN (RESIDUES 54- 65) AND L-ARGININE TEMPLATE INHIBITOR CS107
1wbg ACTIVE SITE THROMBIN INHIBITORS
2hgt ALPHA-THROMBIN COMPLEX WITH HIRULOG I (CLEAVED BETWEEN ARG 3 AND PRO 4)
2hnt GAMMA-THROMBIN
2hpp ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND BOVINE PROTHROMBIN FRAGMENT 2
2hpq ALPHA-THROMBIN COMPLEX WITH D-PHE-PRO-ARG - CHLOROMETHYLKETONE (PPACK) CHLOROMETHYLKETONE REPLACED BY A METHYLENE GROUP AND HUMAN PROTHROMBIN FRAGMENT 2
2thf STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D- PHE-PRO- ARG- CHLOROMETHYLKETONE
3hat ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND FPAM (FIBRINOPEPTIDE A MIMIC)
3htc ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47)
4htc ALPHA-THROMBIN COMPLEX WITH RECOMBINANT HIRUDIN (VARIANT 2, LYS 47)
4thn THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN- HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE.
5gds HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN: HIRUNORM V COMPLEX
7kme CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711.
8kme CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770.